# Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112

> **NCT04375865** · PHASE1 · COMPLETED · sponsor: **Addpharma Inc.** · enrollment: 30 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** AD-2111
- **DRUG:** AD-2112

## Key facts

- **NCT ID:** NCT04375865
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-30
- **Primary completion:** 2020-07-16
- **Final completion:** 2020-07-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04375865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04375865, "Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04375865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*